Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. RYTM $26.1200 -0.6500 % -2.4300 Rhythm Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.43% Wk: 9.58% Mo: […]
Read MoreMarket conditions are Bullish in a Bear Market as of 2022-11-15. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -19.00 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreRevance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. RVNC $27.0000 1.3300 % 5.1800 Revance Therapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 5.18% Wk: […]
Read MoreAxoGen, Inc. (AXGN) AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company’s products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site. AbbVie Inc. (ABBV) AbbVie Inc. […]
Read MoreSatsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. STSA $6.9200 0.4200 % 6.4600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.46% Wk: 7.96% Mo: 17.29% Yrly: 45.07% YTD: 53.78% Strength Rank: […]
Read MoreAVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor. AVEO $7.8800 0.1900 % 2.4700 Aveo Pharmaceuticals Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY […]
Read MoreTitan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. TTNP $1.3900 0.0700 % 5.3000 Titan […]
Read MoreAdicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptors. ACET $18.1800 0.6800 % 3.8900 Adicet Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term […]
Read MoreArdmore Shipping Corporation (ASC) Ardmore Shipping Corporation engages in the seaborne transportation of petroleum products and chemicals worldwide. As of February 15, 2022, the company operated a fleet of 25 double-hulled product and chemical tankers. It serves oil majors, oil companies, oil and chemical traders, chemical companies, and pooling service providers. Comstock Resources, Inc. (CRK) […]
Read MoreMeridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. VIVO $32.5000 -0.0200 % -0.0600 Meridian Bioscience Sector : Medical Industry : Medical Products Signal Short Term Trend […]
Read MoreBuy Price: $243.00 or better Sell Price: TradersPro Sell Signal United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The stocks founds in the One Hot Stock category use stocks that are in […]
Read MoreHarmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. HRMY $52.0000 3.2300 % 6.6200 Harmony Biosciences Holdings Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.62% Wk: 0.64% Mo: 21.35% […]
Read More(Bloomberg) — A four-day rebound in biotechnology stocks may be about to gain momentum after an industry ETF rose above a key resistance level, according to the chief strategist at Miller Tabak. The iShares Nasdaq Biotechnology ETF, or IBB, climbed over its 50-day moving average Friday after twice failing to clear the barrier in the […]
Read More(Bloomberg) — The first year of the Covid-19 pandemic fueled a frenzy for biotechnology stocks. Now, with vaccines in millions of arms and the omicron variant on the wane, there are signs investors are ready to move on. After cresting at nearly $5 billion a month in early 2020, inflows into health-care funds have slowed […]
Read More